author-photo

H J Ehrlich

19

Papers

876

Citations

Citation Trend

Filter By

Papers (12) Sort By

Journal Conference Others

of heparin, vitronectin, and the reactive site On the target specificity of plasminogen activator inhibitor 1: the role

2011
Show All
- Source
- Cite
- Save
Citations (0)
Lack of evidence for increased inhibitor incidence in patients switched from plasma-derived to recombinant factor VIII: FACTOR VIII INHIBITORS

2008 Haemophilia
- I. Scharrer
- H J Ehrlich
Show All
- Source
- Cite
- Save
Citations (0)
CHEMISTRY, BIOLOGY, AND POTENTIAL ROLE IN CLINICAL MEDICINE OF HEMOGLOBIN SOLUTIONS : THE EXAMPLE OF DIASPIRIN CROSSLINKED HEMOGLOBIN (DCLHB)

1998 Clinical Laboratory
- H J Ehrlich
- Robert J. Przybelski
Show All
- Source
- Cite
- Save
Citations (0)
Cytokine efficiency in the treatment of high-grade malignant non-Hodgkin's lymphomas: Results of a randomized double-blind placebo-controlled study with intensified COP-BLAM ± rhGM-CSF

1994 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (21)
Mapping of binding sites for heparin, plasminogen activator inhibitor-1, and plasminogen to vitronectin's heparin-binding region reveals a novel vitronectin-dependent feedback mechanism for the control of plasmin formation.

1992 Journal of Biological Chemistry
Show All
- Source
- Cite
- Save
Citations (126)
Elucidation of structural requirements on plasminogen activator inhibitor 1 for binding to heparin.

1992 Journal of Biological Chemistry
Show All
- Source
- Cite
- Save
Citations (60)
On the target specificity of plasminogen activator inhibitor 1: the role of heparin, vitronectin, and the reactive site

1991 Blood
Show All
- Source
- Cite
- Save
Citations (74)
Vitronectin governs the interaction between plasminogen activator inhibitor 1 and tissue-type plasminogen activator.

1991 Journal of Biological Chemistry
Show All
- Source
- Cite
- Save
Citations (43)
The interaction of plasminogen activator inhibitor 1 with plasminogen activators (tissue-type and urokinase-type) and fibrin: localization of interaction sites and physiologic relevance.

1991 Blood
Show All
- Source
- Cite
- Save
Citations (97)
Structural requirements for the extracellular interaction of plasminogen activator inhibitor 1 with endothelial cell matrix-associated vitronectin.

1990 Journal of Biological Chemistry
Show All
- Source
- Cite
- Save
Citations (104)